caramiphen
This page covers all caramiphen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Lysosomal Pro-X carboxypeptidase, Sigma non-opioid intracellular receptor 1, Muscarinic acetylcholine receptor M1.
Targets
Marketed (1)
- Caraminphen · Neuroscience
Patent intelligence
- caramiphen patent landscape — aggregated cliff calendar, attackable patents, originator estates